Early Phase Clinical Trials: Canada
Well-being, Health and Biomedical Discovery
Deadlines
Academic Unit:
Memorial Deadline: Inquire with RGCS
External Deadline:
Description
Program Overview
The Early Phase Clinical Trials program was created to provide significant support for clinical trials and/or clinical trial sub-studies that have excellent preliminary data.
Funding
Up to $1,500,000 per project over up to 4 years
Eligibility
Principal applicants must be at or above the level of Assistant Professor or equivalent, and be affiliated with a Canada Revenue Agency-qualified donee institution located in Canada.
Project must be a clinical trial and/or a clinical trial sub-study(s) that accelerates the development of therapeutics for neurodegenerative diseases of aging, and must involve the development of a therapeutic, and/or a tool.
For more information, please see the attached Request for Applications (RFA) or visit Weston’s website.
- 1. The Institute has updated which tools are in scope. Please read the What We Fund page on our website before applying to ensure your project is in scope.
2. The Early Phase Clinical Trials program will now be run on a rolling basis.
Contact Information
Cristina Tang, PhD
Senior Research Programs Specialist, Weston Brain Institute
+1 416-965-5356 | cristina.tang@weston.ca | www.westonbraininstitute.ca
Downloads
Early Phase Clinical Trials Canada - RFA